STOCK TITAN

AORT Rule 144 notice: 2,566-share NYSE sale disclosed

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

AORT received a Rule 144 notice for a proposed sale of 2,566 common shares through Fidelity Brokerage Services, with an aggregate market value of $114,492.10. The approximate sale date is 11/11/2025 on the NYSE.

The shares were acquired on 11/07/2025 via restricted stock vesting from the issuer as compensation. A separate table shows a sale of 18,200 shares on 08/27/2025 by Marshall S. Stanton, for $801,211.32 in gross proceeds. Shares outstanding were 47,374,939.

Positive

  • None.

Negative

  • None.

Insights

Routine Rule 144 resale notice; limited market impact.

This is a standard Form 144 indicating intent to sell 2,566 common shares with an aggregate market value of $114,492.10 on the NYSE. The shares were acquired on 11/07/2025 via restricted stock vesting as compensation, which is typical for equity awards.

The excerpt also lists a prior sale of 18,200 shares on 08/27/2025 for $801,211.32. Shares outstanding are reported as 47,374,939, providing baseline context. Actual market effect depends on execution details and trading volume; the notice itself does not change company fundamentals.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does AORT’s Form 144 filing disclose?

It discloses a proposed sale of 2,566 common shares on the NYSE with an aggregate market value of $114,492.10.

When is the proposed sale for AORT shares expected?

The filing lists an approximate sale date of 11/11/2025.

How were the AORT shares to be sold acquired?

They were acquired on 11/07/2025 via restricted stock vesting from the issuer as compensation.

Which broker and exchange are noted for the AORT sale?

Broker: Fidelity Brokerage Services LLC; Exchange: NYSE.

Were there recent AORT share sales by the filer?

A table shows Marshall S. Stanton sold 18,200 shares on 08/27/2025 for $801,211.32 gross proceeds.

How many AORT shares are outstanding?

The filing lists 47,374,939 shares outstanding.
Artivion, Inc.

NYSE:AORT

AORT Rankings

AORT Latest News

AORT Latest SEC Filings

AORT Stock Data

2.22B
43.29M
4.5%
89.88%
2.32%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
KENNESAW